Seeking to boost shareholder returns, Novartis readies new $11B buyback round

Seeking to boost shareholder returns, Novartis readies new $11B buyback round

Source: 
Fierce Pharma
snippet: 

Just as Swiss drug giant Novartis works to wrap up one massive share buyback program, the company has decided to roll out another.

Novartis is preparing to kick off a share buyback round aimed at repurchasing up to 10 billion Swiss francs ($11 billion) worth of company shares in the next three years.